{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T06:51:12Z","timestamp":1777099872555,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ahj.2023.01.011","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T14:58:22Z","timestamp":1674053902000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial): Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial"],"prefix":"10.1016","volume":"259","author":[{"given":"Carl Johan","family":"Malm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joakim","family":"Alfredsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Erlinge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Gudbjartsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarmo","family":"Gunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian H.","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne J.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrik","family":"Sartipy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theis","family":"T\u00f8nnessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2356-2295","authenticated-orcid":false,"given":"Anders","family":"Jeppsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2023.01.011_bib0001","unstructured":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79:197-215."},{"key":"10.1016\/j.ahj.2023.01.011_bib0002","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.01.011_bib0003","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.01.011_bib0004","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1161\/CIR.0000000000000404","article-title":"2016 ACC\/AHA Guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"134","author":"Levine","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.01.011_bib0005","unstructured":"SWEDEHEART annual report 2021. Available at www.swedeheart.se. Accessed Sep 22, 2022."},{"key":"10.1016\/j.ahj.2023.01.011_bib0006","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.jtcvs.2015.08.066","article-title":"Dual antiplatelet therapy use by Canadian cardiac surgeons","volume":"150","author":"Yanagawa","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ahj.2023.01.011_bib0007","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Clopidogrel in unstable angina to prevent recurrent events trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.01.011_bib0008","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.CIR.0000140675.85342.1B","article-title":"Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non\u2013ST-elevation acute coronary syndrome","volume":"110","author":"Fox","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.01.011_bib0009","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jacc.2010.09.069","article-title":"Efficacy of post-operative clopidogrel treatment in patients revascularized with coronary artery bypass grafting after myocardial infarction","volume":"57","author":"S\u00f8rensen","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.01.011_bib0010","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12893-015-0096-z","article-title":"Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials","volume":"15","author":"Verma","year":"2015","journal-title":"BMC Surg"},{"key":"10.1016\/j.ahj.2023.01.011_bib0011","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/jocs.12074","article-title":"Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis","volume":"28","author":"Deo","year":"2013","journal-title":"J Card Surg"},{"key":"10.1016\/j.ahj.2023.01.011_bib0012","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ejcts\/ezx314","article-title":"2017 EACTS Guidelines on perioperative medication in adult cardiac surgery","volume":"53","author":"Sousa-Uva","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ahj.2023.01.011_bib0013","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.01.011_bib0014","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMp1310102","article-title":"The randomized registry trial\u2013the next disruptive technology in clinical research?","volume":"369","author":"Lauer","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.01.011_bib0015","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrcardio.2015.33","article-title":"Registry-based randomized clinical trials\u2013a new clinical trial paradigm","volume":"12","author":"James","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ahj.2023.01.011_bib0016","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jacc.2010.10.029","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial","volume":"57","author":"Held","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.01.011_bib0017","article-title":"Dual antiplatelet therapy with ticagrelor and aspirin is associated with improved survival after CABG: A nationwide study from the SWEDEHEART registry","author":"Malm","year":"2016","journal-title":"Scandinavian Association for Thoracic Surgery 2016"},{"key":"10.1016\/j.ahj.2023.01.011_bib0018","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ahj.2017.01.010","article-title":"Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes","volume":"186","author":"Ducrocq","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2023.01.011_bib0019","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jacc.2015.01.047","article-title":"Association of spontaneous bleeding and myocardial infarction with long-term mortality after percutaneous coronary intervention","volume":"65","author":"Kazi","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.01.011_bib0020","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.01.011_bib0021","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/1740774509105223","article-title":"Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs","volume":"6","author":"Pogue","year":"2009","journal-title":"Clin Trials"},{"key":"10.1016\/j.ahj.2023.01.011_bib0022","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/03009734.2018.1516706","article-title":"When do we need clinical endpoint adjudication in clinical trials?","volume":"124","author":"Held","year":"2019","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.ahj.2023.01.011_bib0023","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/jama.2018.3197","article-title":"Effect of ticagrelor plus aspirin, ticagrelor alone, or aspirin alone on saphenous vein graft patency 1 year after coronary artery bypass grafting: A randomized clinical trial","volume":"319","author":"Zhao","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2023.01.011_bib0024","first-page":"e36","article-title":"Effect of adding ticagrelor to standard aspirin on saphenous vein graft patency in patients undergoing coronary artery bypass grafting (POPular CABG): A randomized, double-blind, placebo-controlled trial","volume":"144","author":"Willemsen","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.01.011_bib0025","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.carrev.2019.10.022","article-title":"A Meta-analysis comparing aspirin alone versus dual antiplatelet therapy for the prevention of venous graft failure following coronary artery bypass surgery","volume":"21","author":"Hesterberg","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.ahj.2023.01.011_bib0026","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/jama.2022.11966","article-title":"Association of dual antiplatelet therapy with ticagrelor with vein graft failure after coronary artery bypass graft surgery: A systematic review and meta-analysis","volume":"328","author":"Sandner","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2023.01.011_bib0027","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","article-title":"Coronary-artery bypass surgery in patients with ischemic cardiomyopathy","volume":"374","author":"Velazquez","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.01.011_bib0028","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.22597","article-title":"Comparison of midterm outcomes associated with aspirin and ticagrelor vs aspirin monotherapy after coronary artery bypass grafting for acute coronary syndrome","volume":"4","author":"Bj\u00f6rklund","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ahj.2023.01.011_bib0029","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijcard.2018.07.083","article-title":"Dual versus single antiplatelet therapy after coronary artery bypass graft surgery: An updated meta-analysis","volume":"269","author":"Cardoso","year":"2018","journal-title":"Int J Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323000182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323000182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:09:19Z","timestamp":1757570959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870323000182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":29,"alternative-id":["S0002870323000182"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2023.01.011","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial): Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2023.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}